Filing Details

Accession Number:
0001415889-25-012541
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-09 17:01:05
Reporting Period:
2025-05-07
Filing Date:
2025-05-09
Accepted Time:
2025-05-09 17:01:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1730430 Kiniksa Pharmaceuticals International Plc KNSA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741533 F. John Paolini
23 Old Bond Street, Third Floor
London X0 W1S 4PZ
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Share Acquisiton 2025-05-07 200 $3.80 57,603 No 4 M Direct
Class A Ordinary Share Disposition 2025-05-07 200 $27.00 57,403 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Ordinary Share Share Option Disposition 2025-05-07 200 $0.00 200 $3.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
65,867 2027-06-28 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 16, 2024.
  2. The option is fully vested and exercisable.